1. Patient Profile & Baseline Demographics
2. Fever Characteristics & Dynamics
3. Immediate Red-Flag Severity Assessment
Check any finding present. Any red-flag elevates patient risk to High or Critical and triggers urgent stabilization, emergency sepsis protocol, or ICU consult.
Structured 9-System Review of Associated Symptoms
Toggle symptoms to pinpoint primary localization, organ involvement, and atypical patterns
Constitutional & General
Respiratory
GI & Hepatobiliary
Neurological
Musculoskeletal
Skin & Mucosa
Genitourinary
Cardiovascular & Vascular
ENT & Ocular
3. Epidemiological, Environmental & Vector Exposure Matrix
Crucial for tropical fever differential in India, Southeast Asia, and global travel medicine
Vector Exposure
Environmental & Water
Food, Water, Travel & Contacts
Past Medical History & Drug Factors
4. Objective Physical Examination Findings
Record targeted vitals, systemic signs, and pathognomonic physical findings
General & Dermatologic Signs
Abdomen & Cardiopulmonary Signs
Neurological & Musculoskeletal Signs
Prioritized Differential Diagnosis Engine
Classified into Common Infectious, Critical Emergencies, and Non-Infectious Etiologies
Step-by-Step Targeted Investigation Recommendation Engine
Tiered ordering sequence to prevent diagnostic delay and avoid indiscriminate over-testing
STAGE 1: Baseline Screening Investigations (Day 1 of Encounter)
Assess leukopenia (common in viral/enteric/dengue), leukocytosis/left shift (bacterial), and baseline hematocrit for hemoconcentration.
Detect early thrombocytopenia (< 100,000/uL) seen in Dengue, Malaria, Leptospirosis, and Scrub Typhus.
Gold standard for Malarial parasites (species & parasite load) + atypical reactive lymphocytes in viral illness.
Screen for Acute Kidney Injury (Weil's disease, severe falciparum, sepsis, hypovolemia).
AST > ALT typical in Dengue; high conjugated bilirubin in Leptospirosis; transaminitis in Scrub & Hepatitis.
Pyuria, bacteriuria, proteinuria (plasma leak / glomerulonephritis), or hemoglobinuria.
STAGE 2: Targeted Pathogen Testing (Tailored to Fever Day & Clinical Suspicion)
NS1 Antigen is highly sensitive during Days 1–5 (viremic phase). After Day 5, Dengue IgM ELISA becomes positive. Never rely on rapid cassette alone without CBC correlation.
Test immediately in endemic regions. Repeat thick/thin smears every 8–12 hours for 48 hours if clinical suspicion remains high despite an initial negative slide.
Highest sensitivity (60–80%) for Salmonella Typhi in the 1st week of illness. Note: Widal test has high false-positive and negative rates; do not use alone for confirmation.
Order whenever there is fever + headache, myalgia, elevated transaminases, or thrombocytopenia. Inspect axillae, groin, and waist for eschar. Empiric Doxycycline advised if suspected.
Indicated with history of floodwater/sewage exposure, conjunctival suffusion, marked calf tenderness, or dual renal and hepatic impairment.
Nasopharyngeal swab in patients presenting with acute cough, rhinorrhea, sore throat, or bilateral lung infiltrates.
STAGE 3: Targeted Imaging & Specialized Procedures
STAGE 4: Second-Line & Prolonged Fever / FUO Workup
Interactive Investigation Input & Dynamic Reassessment Engine
Enter actual or provisional laboratory values to trigger real-time re-ranking of the differential diagnosis
Clinical Interpretation of Current Laboratory Findings
Dynamic Diagnostic Reassessment Matrix
| Diagnosis | Supporting Evidence | Contradictory / Weakening | Post-Lab Probability | Next Recommended Action |
|---|
COMPREHENSIVE CLINICAL FEVER ASSESSMENT REPORT
Structured Clinical Decision Support Summary & Evidenced-Based Pathways
A. Patient Profile & Demographics
- Age/Sex: 32 Y / Male (Weight: 68 kg)
- Immune Status: Immunocompetent
- Residence & Geography: Urban / Peri-urban, India / South Asia
- Comorbidities: None reported
B. Fever Classification & Dynamics
- Recorded Temperature: 39.2 °C (High grade)
- Duration & Category: 4 Days (Acute Febrile Illness)
- Onset & Pattern: Sudden onset, Intermittent fever with chills
- Severity Category: MODERATE RISK (Warning Signs)
C. Key Positive Clinical Signs
D. Epidemiological Exposures
DENGUE FEVER WITH WARNING SIGNS
Supported by acute high-grade fever, severe retro-orbital headache, marked thrombocytopenia (48,000/uL), positive Dengue NS1 antigen on Day 4, AST > ALT, and gallbladder wall thickening with fluid on ultrasound.
- • Severe Dengue / Dengue Shock Syndrome: Monitor for plasma leakage, rising hematocrit, and narrowing pulse pressure (≤ 20 mmHg).
- • Falciparum Malaria / Sepsis: Smear negative; ensure second smear check if fever spikes persist.
H & J. Actionable Diagnostic & Management Recommendations
- Immediate Hospital Admission: Inpatient monitoring in high-dependency unit due to platelet count < 50,000/uL and sonographic fluid leak.
- Judicious Fluid Protocol: Isotonic crystalloid titration (e.g., Normal Saline or Ringer Lactate at 5–7 mL/kg/h for 1–2 hours, stepped down according to clinical response and hematocrit). Avoid fluid overload.
- Daily Monitoring: Serial CBC with hematocrit and platelets every 12–24 hours until 48 hours after defervescence. Strict intake/output charting.
- Avoid NSAIDs / Steroids: Use only Paracetamol (max 3 g/day) for fever relief; absolute contraindication to Aspirin/Ibuprofen/Diclofenac due to hemorrhagic risk.
- Microbial Confirmation: Follow blood cultures; if hypotension or clinical deterioration occurs, re-evaluate for secondary bacterial sepsis.
This system assists clinical decision-making and does not substitute for real-time bedside clinical judgment, formal physical examination, or laboratory confirmation.
Guidelines: WHO Comprehensive Guidelines for Prevention and Control of Dengue (2012/2023) | ICMR Guidelines on Management of Acute Encephalitis Syndrome & Tropical Fevers | NVBDCP Guidelines for Malaria & Dengue Diagnosis | IDSA Guidelines for Evaluation of Fever in Returning Travelers.